₹ 471.65
7.55 (1.63%)
C
Cohance Lifesciences
₹ 471.65
Cohance Lifesciences Share Price Today
Cohance Lifesciences (COHANCE) share price is trading at ₹471.65 on the NSE as of November 12, 2026 at 03:54 PM, up by 1.63% from its previous close of ₹464.10. In todays trading session COHANCE reached a high of 474.00 and low of 457.30. The average traded price for today is 466.84. The 50 DMA stands at 451.97 and 200 DMA is at 410.05. Looking at intraday trend, the stock is in Uptrend.
Stock Overview
- Symbol : COHANCE
- Open : ₹463.30
- Previous Close : ₹464.10
- Day's Range : ₹457.30 – ₹474.00
- 52-Week Range : ₹266.70 – ₹708.05
Get 20+ Chart Types, 180+ Indicators, 80+ Drawing Tools & Create Custom Indicators for FREE.
COHANCE Stock Performance
Markets Today
High
474.00
Low
457.30
Open at
463.30
Prev Close
464.10
Volumes
5,02,632
Avg Price
466.84
Lower Circuit
377.35
Upper Circuit
565.95
Last Traded Details
Quantity
1
Time
15:54:26
Price Movement
Historical Performance
3 M High
493.05
3 M Low
415.00
1 Yr High
708.05
1 Yr Low
266.70
3 Yr High
1,360.00
3 Yr Low
266.70
5 Yr High
1,360.00
5 Yr Low
266.70
1-Year Performance
COHANCE Pros and Cons
Net Fixed Assets grew from ₹35,096 Cr to ₹36,395 Cr over five quarters — continued capacity expansion
Trade Receivables fell from ₹6,810 Cr to ₹4,690 Cr from Q4 FY26 to Q2 FY27 — improved collection efficiency
Net Debt to Adjusted EBITDA improved from 0.71x to 0.25x from Q1 FY27 to Q2 FY27 — stronger debt coverage
Adjusted EBITDA margin collapsed from 23.2% to 10.0% from Q2 FY26 to Q2 FY27 — profitability under severe pressure
Reported PAT swung from ₹1,230 Cr profit to ₹89 Cr loss from Q2 FY26 to Q2 FY27 — bottom line turned negative
Pharma CDMO revenue fell from ₹2,792 Cr to ₹1,678 Cr from Q4 FY26 to Q2 FY27 — key segment revenue declining
Working capital days rose from 121 to 148 from Q2 FY26 to Q2 FY27 — slower cash conversion cycle
ROCE dropped from 21.7% to 3.2% from Q2 FY26 to Q2 FY27 — capital efficiency significantly reduced
COHANCE Analyst Rating
Buy
Analysts have suggested that investors can
Buy this Stock
- By Refinitiv from 9 analysts
Buy
44.44%
Hold
11.11%
Sell
44.44%
Get forecast for Price, ROA & ROE based on analyst ratings.
COHANCE Share Price History
COHANCE Fundamentals
Company Valuation
Market Cap (₹ Cr.)
18,045
PE Ratio
-3,097.00
PB Ratio
4.54
Dividend Yield
1.29%
ROE
3.72%
ROCE
4.81%
Book Value (₹)
102.25
Face Value (₹)
1.00
Analyse COHANCE with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 57.49% | 57.49% | 57.49% | 57.49% | 57.48% |
| Domestic Institutional Investors (DII) | 20.82% | 21.57% | 21.79% | 20.09% | 18.86% |
| Foreign Institutional Investors (FII) | 6.51% | 6.02% | 5.59% | 6.50% | 7.71% |
| Public Investors | 6.42% | 6.76% | 7.04% | 7.71% | 7.50% |
| Government | 0.01% | 0.01% | 0.01% | 0.01% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
Cohance Lifesciences Return Calculator
Note: Past profits do not guarantee future returns.
COHANCE Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
COHANCE Technicals
Moving Averages
Technical Indicators
Summary of Technical Indicators for COHANCE
Margin on COHANCE
*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).
COHANCE Financials Summary
In Crores
COHANCE Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Corporate Actions
The above dates are ex-dates.
Check COHANCE latest Company Filings, Investor Presentation & Conference Call details.
COHANCE Revenue Growth
All values are in Crores
Revenue
Profit
Loss
COHANCE Similar Stocks
FAQs on COHANCE
What is the share price of Cohance Lifesciences?
What is the 52W high and 52W low of Cohance Lifesciences?
What is the return on Cohance Lifesciences share?
- Past 1 year: -31.75%
- Past 3 years: -18.78%
- Past 5 years: -9.14%
What is the PE and PB Ratio of Cohance Lifesciences?
What is the EPS of Cohance Lifesciences?
What is the shareholding pattern of Cohance Lifesciences?
- DIIs - 18.86%
- FII - 7.71%
- Promoters - 57.48%
- Public Investors 7.50%
- Goverenment - 0.00%
How to buy Cohance Lifesciences shares online?
How to buy Cohance Lifesciences shares on Dhan?
- Download the Dhan App to Open a Demat Account
- Navigate to the “Money Tab”
- Add money to your account
- Search for Cohance Lifesciences share
- Tap on “Buy”
